Interleukin-13: Central Mediator of Allergic Asthma

The worldwide incidence, morbidity, and mortality of allergic asthma are increasing. The pathophysiological features of allergic asthma are thought to result from the aberrant expansion of CD4$^+$ T cells producing the type 2 cytokines interleukin-4 (IL-4) and IL-5, although a necessary role for the...

Full description

Saved in:
Bibliographic Details
Published in:Science (American Association for the Advancement of Science) Vol. 282; no. 5397; pp. 2258 - 2261
Main Authors: Wills-Karp, Marsha, Luyimbazi, Jackie, Xu, Xueying, Schofield, Brian, Neben, Tamlyn Y., Karp, Christopher L., Donaldson, Debra D.
Format: Journal Article
Language:English
Published: Washington, DC American Society for the Advancement of Science 18-12-1998
American Association for the Advancement of Science
The American Association for the Advancement of Science
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The worldwide incidence, morbidity, and mortality of allergic asthma are increasing. The pathophysiological features of allergic asthma are thought to result from the aberrant expansion of CD4$^+$ T cells producing the type 2 cytokines interleukin-4 (IL-4) and IL-5, although a necessary role for these cytokines in allergic asthma has not been demonstrable. The type 2 cytokine IL-13, which shares a receptor component and signaling pathways with IL-4, was found to be necessary and sufficient for the expression of allergic asthma. IL-13 induces the pathophysiological features of asthma in a manner that is independent of immunoglobulin E and eosinophils. Thus, IL-13 is critical to allergen-induced asthma but operates through mechanisms other than those that are classically implicated in allergic responses.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0036-8075
1095-9203
DOI:10.1126/science.282.5397.2258